Command Palette

Search for a command to run...

kwality-pharmaceuticals

871.35-0.03%
Market Cap
₹904.44 Cr
Stock P/E
20.83
ROCE
18.36%
ROE
16.36%
Book Value
₹265.19

Financials

YoY Net Sales
EPS Growth
Operating Margin

You might have missed

No Recent News

No recent news available for this stock.

Shareholding

Holdings
Distribution
Promoter
Public
Others

From Last Concall

No Concall Summary

Conference call summary is not available for this stock.

Peers Summary

Sector Leader

Kwality Pharmaceuticals Ltd. stands out in terms of revenue growth and valuation attractiveness compared to its peers. While it shows strong growth metrics, its profitability and debt levels are competitive, with several peers showing either overvaluation or financial stress. As a result, Kwality Pharmaceuticals presents a favorable investment opportunity in the current pharmaceutical landscape.

Key Points
  • Kwality Pharmaceuticals shows the highest revenue growth YoY at 22.36% and a competitive PEG ratio of 0.67.
  • Dr. Reddy's Laboratories leads in profitability metrics with the highest ROE (21.76%) and ROCE (26.86%).
  • Divi's Laboratories is marked as financially weak due to negative revenue growth over 3 years and high valuation ratios.
Top Performers
Dr. Reddy's Laboratories Ltd.

Highest ROE and ROCE showing strong profitability.

Kwality Pharmaceuticals Ltd.

Highest revenue growth YoY and competitive valuation metrics.

Cipla Ltd.

Strong profitability with low PE ratio and solid growth.

Leveling the playing field in markets.

© 2025 EQHQ Technologies Pvt Ltd

"Information provided is for educational purposes only and not financial advice.